重组纳武单抗注射溶液免疫疗法PD-1抑制剂Opdivo(nivolumab 纳武单抗)注射剂在日本批准治疗晚期黑色素瘤、转移性肾细胞癌、转移鳞状非小细胞肺癌、经典霍奇金淋巴瘤、头颈癌。药物分类名称-抗肿瘤药-人抗人PD-1单克隆抗体商標名OPDIVO一般名:ニボルマブ(遺伝子組換え)Nivolumab(Genetical Recombination)分子量約:145,0...
OPDIVO (nivolumab) injection for intravenous use is supplied in single-dose vials. Each mL of OPDIVO solution contains nivolumab 10 mg, mannitol (30 mg), pentetic acid (0.008 mg), polysorbate 80 (0.2 mg), sodium chloride (2.92 mg), sodium citrate dihydrate (5.88 mg), and Water for Injec...
2019-05-09 nivolumab 注射液 | ctr20170541 | 进行中 (招募完成) | bristol-myers squibb company | 2017-06-29 注射用伏立康唑 | ctr20201059 | 已完成 | 信泰制药(苏州)有限公司 | 2020-06-10 注射用头孢嗪脒钠 | ctr20230788 | 进行中 (尚未招募) | 广州白云山医药集团股份有限公司白云山制药总厂...
产地国家:日本处方药:是所属类别:240毫克/瓶包装规格:240毫克/瓶计价单位:瓶生产厂家英文名:Ono Pharmaceutical原产地英文商品名:Opdivo injection(オプジーボ点滴静注) 240mg/vial原产地英文药品名:nivolumab中文参考商品译名:Opdivo注射液(オプジーボ点滴静注) 240mg/vial中文参考药品译名:纳武单抗重组 简介: 部份...
2021-04-19 nivolumab 注射液 | ctr20192398 | 主动终止 | bristol-myers squibb company | 2019-12-18 relatlimab注射液 | ctr20221168 | 进行中 (招募中) | bristol-myers squibb company | 2022-05-16 mpdl3280a注射剂 | ctr20181628 | 进行中 (招募完成) | f.hoffmann-la roche ltd | 2018-11-...
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors Pearl Steinzor FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients. December 18th 2024 Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander ...
Nivolumab(NIVO) is an IgG-4 mAb that blocks PD-1, and ipilimumab(IPI) an IgG-1 mAb that blocks CTLA-4. In a clinical trial for recurrent glioblastoma (BMS CheckMate143), combination of NIVO and IPI administered IV caused unacceptable toxicity. Animal models showed that intratumoral ...
Regular out- patient review, enhancement CT on October 30, 2018: a liver lesion of 14.0×10.0 cm in size, From November 22, 2018, to March 05, 2019, patients with lenvatinib (8mg orally every day) combined with nivolumab injection (140mg intrave- nously every 2 weeks) treatment. ...
Opdivo (nivolumab) is an immunotherapy treatment that treats melanoma, non-small cell lung cancer ... Reviews & ratings 5.4 / 10 90 Reviews View more Keytruda Keytruda (pembrolizumab) is an immunotherapy medication that treats multiple types of cancer by ... Reviews & ratings 4.8 / 10 24...
OPDIVO (nivolumab) injection for intravenous use is supplied in single-dose vials. Each mL of OPDIVO solution contains nivolumab 10 mg, mannitol (30 mg), pentetic acid (0.008 mg), polysorbate 80 (0.2 mg), sodium chloride (2.92 mg), sodium citrate dihydrate (5.88 mg), and Water for Injec...